Bank Julius Baer & Co. Ltd, Zurich Lantern Pharma Inc. Transaction History

Bank Julius Baer & Co. Ltd, Zurich

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 09, 2022	SELL	$5.6 - $8.22 $14,000 - $20,550	-2,500 Closed	0 $0
Q4 2021 Feb 15, 2022	BUY	$7.11 - $11.04 $7,110 - $11,040	1,000 Added 66.67%	2,500 $20,000
Q3 2021 Nov 12, 2021	BUY	$10.53 - $14.93 $4,980 - $7,061	473 Added 46.06%	1,500 $17,000
Q2 2021 Jul 23, 2021	BUY	$12.94 - $19.89 $349 - $537	27 Added 2.7%	1,027 $15,000
Q1 2021 May 10, 2021	BUY	$14.34 - $21.92 $14,340 - $21,920	1,000 New	1,000 $18,000

1.28M

39.8K

6.1K

Ticker LTRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 10,830,900
Market Cap $54.2M
Description
Lantern Pharma Inc., a clinical stage biotechnology company, focuses on artificial intelligence, machine learning, and genomic data to streamline the drug development process. Its advanced drug candidate is LP-100, which is in phase II clinical trials to treat metastatic, castration-resistant, and prostate cancer. The company also develops LP-30...

Get notified when there are updates to the investment portfolio of Bank Julius Baer & Co. Ltd, Zurich, based on Form 13F filings with the SEC.

Stay updated on Bank Julius Baer & Co. Ltd, Zurich with notifications on news.